
Reset all filters
01 4AbbVie Inc
02 2Aurobindo Pharma Limited
Reset all filters
01 4TABLET
02 2TABLET;ORAL
Reset all filters
01 2RX
02 4Blank
Reset all filters
01 4UBRELVY
02 2UBROGEPANT
Reset all filters
01 2Canada
02 4USA
Regulatory Info : RX
Registration Country : USA
Brand Name : UBRELVY
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2019-12-23
Application Number : 211765
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : UBRELVY
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2019-12-23
Application Number : 211765
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Canada
Brand Name : UBRELVY
Dosage Form : TABLET
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 2532530
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : UBRELVY
Dosage Form : TABLET
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 2532581
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : USA
Brand Name : UBROGEPANT
Dosage Form : TABLET
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 219088
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : UBROGEPANT
Dosage Form : TABLET
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 219088
Regulatory Info :
Registration Country : USA